Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6K Buy
97
+66
+213% +$4.4K ﹤0.01% 729
2026
Q1
$1K Sell
31
-14
-31% -$975 ﹤0.01% 1008
2025
Q4
$2K Buy
45
+8
+22% +$517 ﹤0.01% 860
2025
Q3
$2K Sell
37
-43
-54% -$3.4K ﹤0.01% 843
2025
Q2
$6K Buy
80
+22
+38% +$1.72K ﹤0.01% 573
2025
Q1
$4K Hold
58
﹤0.01% 578
2024
Q4
$4K Sell
58
-37
-39% -$2.74K ﹤0.01% 576
2024
Q3
$6K Sell
95
-38
-29% -$3.12K ﹤0.01% 478
2024
Q2
$15K Buy
133
+76
+133% +$9.61K ﹤0.01% 262
2024
Q1
$8K Buy
57
+6
+12% +$754 ﹤0.01% 349
2023
Q4
$6K Buy
51
+47
+1,175% +$4.8K ﹤0.01% 360
2023
Q3
$0 Sell
4
-24
-86% -$2.71K ﹤0.01% 898
2023
Q2
$2K Buy
+28
New +$3.39K ﹤0.01% 465

Other funds holding DXCM

Avion Wealth's DXCM Position: Q2 2026 in Review

Avion Wealth increased its DexCom (DXCM) stake by 213% in Q2 2026, buying an estimated $4.4K and bringing the position to 97 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Avion Wealth first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $15K in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Avion Wealth held 97 shares of DexCom worth $6K as of Q2 2026.
  • Avion Wealth bought 66 DexCom shares in Q2 2026, an estimated $4.4K.
  • DexCom made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #729 holding.
  • Avion Wealth first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • Avion Wealth's DexCom position peaked at $15K in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.